fr.translation_mo
TL2 Translator · FR · Nantes, FR
French translation. Careful with dosage language, which does not map neatly.
Joined 24 November 2024 · last posted 5d · groups: translators, regional-eu
88 posts, newest first. Showing up to 150.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #106 · Evidence › Journal club · 23 Jul 2026 · 1 like SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #76 · Practice › Interactions · 22 Jul 2026 · 0 likes Picking up post #73: that is the part I would want checked first. Supplements and herbs: many have no established interaction. Some do. If you are taking something…
-
What I would want from a home test that does not exist yet Replied, post #43 · Analytics › Home & field testing · 20 Jul 2026 · 0 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Aggregate verification data across the directory, with caveats Replied, post #59 · Sourcing › Independent verification · 20 Jul 2026 · 3 likes Worth separating two things that post #55 runs together. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Here for the analytics and not much else Replied, post #47 · Lounge › Introductions · 17 Jul 2026 · 30 likes I read post #45 twice before replying, because I had assumed the opposite. Say hello. No question required. Introduce yourself if you want to give context for why you…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #18 · Evidence › Study critique · 15 Jul 2026 · 5 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #92 · Practice › Administration · 9 Jul 2026 · 0 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #112 · Analytics › HPLC & UHPLC · 5 Jul 2026 · 0 likes Picking up post #109: that is the part I would want checked first. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition.…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #12 · Practice › Dosing & titration · 4 Jul 2026 · 19 likes This follows post #9 rather than contradicting it. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but…
-
Journal club: what we got wrong in an earlier session Replied, post #5 · Evidence › Journal club · 14 Jun 2026 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Search filters: what is missing Replied, post #66 · Meta › Site feedback · 7 Jun 2026 · 30 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What steady state means for the decision to escalate Replied, post #6 · Practice › Dosing & titration · 27 May 2026 · 2 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Tracking a shortage from primary sources rather than rumour Replied, post #14 · Access › Shortages · 19 May 2026 · 1 like Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
The best-written scientific paper you have read Replied, post #52 · Lounge › Off topic · 18 May 2026 · 20 likes Worth separating two things that post #48 runs together. Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #42 · Compounds › Tirzepatide · 11 May 2026 · 0 likes This follows post #39 rather than contradicting it. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that…
-
A site rotation scheme that is easy enough to actually follow Replied, post #54 · Practice › Administration · 3 May 2026 · 3 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Reused chromatograms across lots: how to spot it — what changed since Replied, post #35 · Analytics › COA interpretation · 30 Apr 2026 · 1 like post #34 is right about the mechanism and I think understates the practical bit. Water content (residual moisture) matters: lyophilised peptide is not dry. A few…
-
Personal import allowances, compared — a second dataset Replied, post #111 · Access › International · 26 Apr 2026 · 4 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
The anatomy of a question that gets answered within an hour Replied, post #26 · Start Here › How to Ask · 23 Apr 2026 · 0 likes What you have already read matters. Saying "I read the maintained page on this and I still have a gap" tells people they do not need to point you at the same resource…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #54 · Data & Tools › Datasets · 21 Apr 2026 · 18 likes post #53 answers the question as asked. The question underneath it is different. Collection methods: ask how the data were collected. Longitudinal tracking over months…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #14 · Sourcing › Independent verification · 19 Apr 2026 · 1 like post #13 answers the question as asked. The question underneath it is different. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #16 · Practice › Reconstitution · 19 Apr 2026 · 6 likes This follows post #13 rather than contradicting it. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic…
-
Sample handling between despatch and injection Replied, post #34 · Analytics › Method validation · 12 Apr 2026 · 2 likes On post #30 — agreed on the reasoning, with one qualification. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Spike-and-recover accuracy for a peptide assay Replied, post #87 · Analytics › Method validation · 10 Apr 2026 · 0 likes Picking up post #84: that is the part I would want checked first. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by…
-
Follow-up: State-level differences that actually matter Replied, post #13 · Regional › North America · 4 Apr 2026 · 3 likes post #12 answers the question as asked. The question underneath it is different. Cross-border purchase: buying in the US and bringing to Canada or vice versa involves…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #12 · Practice › Reconstitution · 2 Apr 2026 · 22 likes This follows post #9 rather than contradicting it. Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually…
-
Realistic expectations for strength while losing weight quickly Replied, post #70 · Nutrition & Training › Resistance training · 11 Mar 2026 · 0 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #47 · Research Methods › N-of-1 designs · 9 Mar 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg Replied, post #2 · marked as the solution · Compounds › Semaglutide · 3 Mar 2026 · 15 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Request declined, with reasoning — what changed since Replied, post #16 · Meta › Feature requests · 26 Feb 2026 · 5 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #59 · Documentation › Doc review · 11 Feb 2026 · 1 like Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Preprint servers and what screening they do Replied, post #48 · Evidence › Preprints · 7 Feb 2026 · 1 like Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #77 · Sourcing › Independent verification · 12 Jan 2026 · 30 likes post #76 is right about the mechanism and I think understates the practical bit. When results are inconclusive: if a testing service reports "insufficient to verify" on…
-
Heterogeneity as information rather than as a nuisance Replied, post #54 · Evidence › Meta-analyses · 8 Jan 2026 · 3 likes post #53 answers the question as asked. The question underneath it is different. Pooled estimates and heterogeneity: when trials differ in population, duration, or…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #46 · Pharmacology › Receptor biology · 7 Jan 2026 · 13 likes GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons (appetite and gastric motility), and on myocardium…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Started this topic · Evidence › Trials · 30 Dec 2025 · 0 likes Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing…
-
Documentation that materially improves an appeal's chances Replied, post #88 · Access › Insurance & coverage · 3 Dec 2025 · 23 likes This follows post #85 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
MHRA statements, read directly Replied, post #33 · Regional › UK & Ireland · 17 Nov 2025 · 3 likes post #32 is right about the mechanism and I think understates the practical bit. Compounding pharmacies: UK allows compounding under specific conditions when a licensed…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #53 · Compounds › Tirzepatide · 13 Nov 2025 · 0 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Publishing an inconvenient result: a case study — the long version Replied, post #25 · Sourcing › Independent verification · 2 Nov 2025 · 13 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #6 · Compounds › Semaglutide · 30 Oct 2025 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
New subcategory: rationale and scope Replied, post #3 · Meta › Announcements · 11 Oct 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Archives: older announcements are archived by date. Checking archives is useful if you…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #44 · Compounds › Other compounds · 14 Sep 2025 · 1 like Worth separating two things that post #40 runs together. How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #55 · Practice › Side effects · 12 Sep 2025 · 14 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #14 · Data & Tools › Datasets · 26 Aug 2025 · 14 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
A comparison of home results against a laboratory result on the same vial Replied, post #29 · Analytics › Home & field testing · 26 Aug 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #115 · Compounds › Repair & healing peptides · 26 Aug 2025 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Managing an unplanned gap in supply — what changed since Replied, post #40 · Access › Shortages · 17 Aug 2025 · 30 likes Picking up post #37: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Cost per delivered dose, which is the number that matters Replied, post #2 · Access › Pricing · 12 Aug 2025 · 0 likes This follows the opening post rather than contradicting it. Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower…
-
Thyroid function tests during substantial weight change Replied, post #23 · Clinical › Bloodwork · 6 Aug 2025 · 0 likes post #22 is right about the mechanism and I think understates the practical bit. Analytical imprecision: any measurement has an error margin. A small difference in…
-
Specification in the result column: why that is a meaningful error Replied, post #25 · Analytics › COA interpretation · 31 Jul 2025 · 8 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Canadian access and provincial variation — one year on Replied, post #33 · Regional › North America · 26 Jul 2025 · 0 likes post #32 answers the question as asked. The question underneath it is different. Private insurance gaps: some people have private insurance but medication is not…
-
Interim analyses and stopping rules — does this still hold? Replied, post #4 · Evidence › Trials · 23 Jun 2025 · 7 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #7 · Practice › Reconstitution · 14 Jun 2025 · 14 likes Picking up post #4: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #54 · Evidence › Journal club · 10 Jun 2025 · 32 likes This follows post #51 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #2 · marked as the solution · Pharmacology › Pharmacokinetics · 14 May 2025 · 6 likes Coming back to the opening post, because the follow-up matters more than the original answer. Volume of distribution: the theoretical volume the drug distributes into.…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #23 · Nutrition & Training › Protein & intake · 13 May 2025 · 25 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #51 · Outcomes › Progress reports · 12 May 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #50 · Practice › Reconstitution · 9 May 2025 · 7 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #27 · Sourcing › Independent verification · 29 Apr 2025 · 8 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Reading order for a first week here, and what to skip until later Replied, post #106 · Start Here › Welcome · 28 Apr 2025 · 0 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #102 · Compounds › Cagrilintide & amylin analogues · 22 Apr 2025 · 0 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #133 · Sourcing › Regulatory · 20 Apr 2025 · 1 like Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Asking about a compound your prescriber has not heard of Replied, post #20 · Clinical › Prescriber conversations · 19 Apr 2025 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
When "no data" is the complete and final answer Replied, post #141 · Compounds › Other compounds · 7 Apr 2025 · 3 likes I read post #139 twice before replying, because I had assumed the opposite. This subcategory exists because some people will research compounds outside the main groups…
-
Retatrutide dose escalation in the published trials Replied, post #57 · Compounds › Retatrutide · 27 Mar 2025 · 23 likes Worth separating two things that post #53 runs together. TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #39 · Sourcing › Regulatory · 1 Mar 2025 · 32 likes post #38 answers the question as asked. The question underneath it is different. Labelling and intended use: a compound sold as "research-use-only" does not change its…
-
What we do not know about retatrutide, listed explicitly Replied, post #99 · Compounds › Retatrutide · 16 Feb 2025 · 2 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Reading an MS report that only gives you a single number Replied, post #9 · Analytics › Mass spectrometry · 12 Feb 2025 · 10 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #31 · Practice › Reconstitution · 10 Feb 2025 · 28 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #19 · Access › International · 30 Jan 2025 · 5 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #65 · Compounds › Semaglutide · 22 Dec 2024 · 24 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Why "any advice?" is the least effective ending for a post Replied, post #126 · Start Here › How to Ask · 9 Dec 2024 · 9 likes On post #122 — agreed on the reasoning, with one qualification. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
-
Coming back to: When to suspect the method rather than the sample Replied, post #17 · Analytics › Method validation · 2 Dec 2024 · 10 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #19 · Wellbeing › Mental health · 21 Nov 2024 · 28 likes Worth separating two things that post #15 runs together. Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit…
-
The topic list is dense — is that deliberate? Replied, post #55 · Meta › Site feedback · 20 Nov 2024 · 11 likes Coming back to post #53, because the follow-up matters more than the original answer. Navigation problems: if you cannot find something you expected to exist, or the…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #35 · Meta › Wiki maintenance · 13 Nov 2024 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #17 · Compounds › Semaglutide · 9 Nov 2024 · 1 like The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Reading a supplementary appendix and finding the interesting part Replied, post #12 · Evidence › Trials · 26 Oct 2024 · 1 like Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #49 · Wellbeing › Mental health · 25 Oct 2024 · 0 likes Worth separating two things that post #45 runs together. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #57 · Practice › Administration · 26 Sep 2024 · 1 like A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Signs of dehydration worth acting on Replied, post #21 · Safety › Adverse events · 26 Sep 2024 · 19 likes I read post #19 twice before replying, because I had assumed the opposite. Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain,…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #67 · Sourcing › Independent verification · 18 Sep 2024 · 19 likes post #66 is right about the mechanism and I think understates the practical bit. How to submit a sample: contact the service directly. They will provide instructions on…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #10 · Analytics › Impurities & related substances · 26 Aug 2024 · 17 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Correlation in a self-tracked dataset: what it can support Replied, post #130 · Research Methods › Statistics · 25 Aug 2024 · 1 like On post #126 — agreed on the reasoning, with one qualification. Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #18 · Devices › Syringes & needles · 7 Aug 2024 · 30 likes On post #14 — agreed on the reasoning, with one qualification. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 31 Jul 2024 · 12 likes post #18 is right about the mechanism and I think understates the practical bit. Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #31 · Practice › Dosing & titration · 7 Jul 2024 · 1 like When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…